Cigna Group sets Q2 earnings date, shares tracked against S&P 500 peers

Cigna Group has scheduled its next quarterly report for early August on the NYSE. Analysts still see the health insurer as part of a robust U.S. managed-care cohort as investors watch earnings expectations and valuation.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-23, 09:14.

Cigna Group (US1255231003) prepares for its next earnings release on the NYSE with a scheduled second-quarter update in early August 2026, according to the company’s investor relations calendar. The health insurer remains part of the U.S. managed-care cohort alongside peers such as UnitedHealth and Elevance Health, with consensus figures framing expectations for the coming months.

What consensus estimates signal

Analyst overviews compiled by financial portals such as MarketWatch and MarketScreener show that Cigna is covered by a broad group of Wall Street banks and research houses, including Goldman Sachs, JPMorgan and Morgan Stanley, with the stock generally rated between Hold and Buy categories across the consensus spectrum. Public consensus snapshots indicate that most analysts still expect mid-single-digit revenue growth in 2026, driven by the Evernorth health services segment and the U.S. commercial insurance book. MarketWatch analyst estimates overview

Across recent summaries of 12-month price targets, the average target price for Cigna shares typically stands moderately above the current market level, indicating that the street still sees some upside versus spot, even if the upside is more muted than for high-growth technology names. Analyst distributions show that Buy and Overweight ratings dominate, while a smaller group of houses stays Neutral or Equal-Weight, often citing valuation and policy risks in the U.S. healthcare system. MarketScreener consensus summary for Cigna

Position in the U.S. health sector

In the S&P 500, Cigna sits in the health care sector alongside larger managed-care players such as UnitedHealth Group and Elevance Health and pharmacy-focused groups like CVS Health, giving investors a range of comparables for valuation and earnings momentum. Sector reports from outlets including Reuters and Bloomberg underline that the managed-care space continues to trade at earnings multiples below the broader index, reflecting regulatory scrutiny and reimbursement uncertainties in U.S. programs such as Medicare Advantage. Reuters analysis on U.S. health insurers

Relative to these peers, Cigna’s focus on commercial insurance and health services through Evernorth means its earnings mix differs from that of Medicare-heavy competitors, which can affect how the shares react to regulatory headlines and reimbursement decisions. For many investors, this differing mix is part of the argument for diversification within the U.S. health insurance space, spreading exposure between commercial, government and services revenue streams rather than concentrating on a single reimbursement channel.

How Cigna earns its money

Cigna generates its revenue primarily through two segments: Cigna Healthcare, which offers medical, pharmacy and behavioral health coverage to U.S. employers and other groups, and Evernorth Health Services, which provides pharmacy benefit management, specialty pharmacy and related care services. Recent filings detail that a significant portion of group revenue stems from pharmacy benefits and integrated care management, reflecting the strong expansion of Evernorth in recent years. In addition, Cigna operates international health insurance offerings serving expatriates and multinational companies, which adds geographic diversification to its predominantly U.S.-centric business model. Cigna Group business overview

Where the stock trades today

The Cigna Group shares (US1255231003) most recently traded on the NYSE at around 282 US dollars per share with a market capitalization in the mid-80-billion-dollar range, based on exchange data as of 2026-06-22, 22:00 New York time.

Key data on the Cigna Group shares

• Company: The Cigna Group, Inc.
• ISIN: US1255231003
• WKN: A3ESR8
• Ticker: CI
• Trading venue: NYSE
• Price (as of 2026-06-22, 22:00): 282.00 USD
• Market cap: approximately 85 billion USD (as of 2026-06-22)
• Sector / industry: Health Care / Managed Health Care and Health Services
• Index membership: S&P 500
• Next earnings date: 2026-08-01

Disclaimer: This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any financial instruments. Neither specific investment recommendations nor price targets are provided. Investors should conduct their own research and consider their individual financial situation and risk profile before making investment decisions.